These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway. Marchetti S, Guzzetta G, Flem E, Mirinaviciute G, Scalia Tomba G, Manfredi P. Vaccine; 2018 Feb 14; 36(8):1116-1125. PubMed ID: 29366704 [Abstract] [Full Text] [Related]
7. Varicella and herpes zoster vaccine development: lessons learned. Warren-Gash C, Forbes H, Breuer J. Expert Rev Vaccines; 2017 Dec 14; 16(12):1191-1201. PubMed ID: 29047317 [Abstract] [Full Text] [Related]
10. Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice. Xue W, Li T, Zhang S, Wang Y, Hong M, Cui L, Wang H, Zhang Y, Chen T, Zhu R, Chen Z, Zhou L, Zhang R, Cheng T, Zheng Q, Zhang J, Gu Y, Xia N, Li S. Viruses; 2022 Aug 16; 14(8):. PubMed ID: 36016407 [Abstract] [Full Text] [Related]
12. [Varicella-pox virus infection: features of the course, clinical manifestations, complications, and possibilities for prevention]. Prikhodchenko NG. Ter Arkh; 2021 Nov 15; 93(11):1401-1406. PubMed ID: 36286666 [Abstract] [Full Text] [Related]
20. Advances in the treatment of varicella-zoster virus infections. Andrei G, Snoeck R. Adv Pharmacol; 2013 Dec 15; 67():107-68. PubMed ID: 23886000 [Abstract] [Full Text] [Related] Page: [Next] [New Search]